Philip Morris
Traps and Errors in Risk Analysis
Fields
- Author
- Wilson, R.
- Area
- LOGUE,MAYADA/OFFICE
- Type
- REPT, REPORT, OTHER
- CHAR, CHART, GRAPH, TABLE, MAPS
- DRAW, DRAWING
- FOOT, FOOTNOTES
- CHAR, CHART, GRAPH, TABLE, MAPS
- Site
- N426
- Request
- Stmn/R1-072
- Named Organization
- Congress
- Division of Vital Statistics
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- Monsanto
- Nas, Natl Academy of Sciences
- Natl Center for Health Statistics
- New Yorker
- Nyu
- OSHA, Occupational Safety & Health Administration
- Oxford
- Park Service
- Rosswell Memorial Hospital
- Technology Review
- Toxicology Forum
- US Supreme Court
- Varian Associates
- Hew, Dept of Health Education and Welfare
- Bnl
- Carcinogen Assessment Group
- Division of Vital Statistics
- Named Person
- Bond, V.
- Bross
- Burger
- Carson, R.
- Cromwell
- Crouch
- Delaney
- Doll, R.
- Epstein, S.
- Florman, S.C.
- Ginzton, E.
- Johnson, S.
- Wilson, R.
- Bross
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Litigation
- Stmn/Produced
- Author (Organization)
- George Washington Univ Dc
- Harvard Univ Cambridge
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- lmp02a00
Document Images
-7-
but there was a draconian penalty---death. However all juries
violated the rules, and no jury would convict anyone accused of
the crime.
Similarly if a group of assessors are asked an inappropriate
question, or suspect that their answer may lead to stupid dracon-
ian measures, they may well decide not to state the true opinion.
Thus :'.f the question is merely "is this chemical a carcinoaen"
with no question of potency, I believe it is now inappropriate.
If it is coupled with a draconian action of a complete unquestioning
ban if the answer is yes, many scientists will refuse to play the
game
We can enter this diagram at any point; but usually it will
be the decision maker who asks for an assessment. We must also be
aware that if well done, a risk assessment may illuminate several
different decisions. For example, the risk assessment for benzene
may apply either in the workplace, or for the environment.
F,rrors often arise from not realizing that there are dif-
ferent constituencies in risk decisions and each constituency
must be satisfied. It is an error to calculate the average risk
to society, show that it is small and ignore it in spite of the
large risk to an individual segment. I illustrate this by cal-
culating the risk of being killed by a bear in Glacial National
Park According to the figures available to me, and as a risk
asses-sor I,accept this data, 2 people were killed in 1967; 1
person in 1975; and 3 people in 1980. That amounts to 6 people
over about 15 years, or 0.4 per year. The Park Service informs

- 8 -
me that the total number of park visitors is 1,500,000/yr; about
18,000backpack cam.pers/yr (25,000 permit nights); and about 1000 em-
ployees of park concessions. Of the 6 people killed, all were backpackers,
and 4 were concession employees.*
'T'he risk averaged over the whole U.S. population is:
5 x 220,000,000 - 2 x 10-9 per year.
I do not expect the President of the U.S. to lose sleep over it.
It is a de minimis risk.
'The risk averaged over park visitors is:
17 x 1,500,000 = 3 x 10-7 per year;
still de minimis by my criterion, but on the border of worth
bothering about and indeed the park service have done little.
'rhe risk as a fraction of backpack campers is:
1-5 x 18 000 = 2 x- 10-5 per year.
r
This is a voluntary risk worth reducing, but probably
acceptable and,
indeed, my wife and I accepted it a few summers ago (but we did take
care; put bells on our packs and hung the food on poles).
The risk as a fraction of park concession employees is
1 x l~- = 3 x 10-4 per year.
This is now large, as large as the risk of driving a car to get
N
to Glacier Park in the first place, and probably worth addressing ~
by the representatives of this smaller group. ~
But this analysis leads, if we are not careful, to another ~
trap., Why do you include in the denominator those who are not ~
~
~
*
This is based on oral statements only.

-9-
expos,e:d? Because we may know no better. But we should go on
reducing the size of the denominator until one reaches a logical
trap. We should include in the denominator all those "at risk"
and not only those who were killed.c We get 6/6 or a risk of unity
when we identify the group at risk as the group actually sleeping
in the: path of the bears and subsequently mauled. The denominator
must be chosen so that the risk calculation has predictive power.
To restrict the denominator too much takes away that power.
Bross, of the Rosswell Memorial Hospital in Buffalo, fell into
this trap when discussing leukemia incidence. He restricted the
group at risk to those who already had health problems which are
precursers of leukemia. As shown by Bond6 his calculations have
no predictive power.
Another error is to assume that a risk benefit analysis should
be constant for all time. This omits the possibility of techno-
logy i.mprovement. It is clear that the public wants risk to be
reduced, and will not stand for additional risks being introduced
to soc:iety--unless there is an obvious compensating risk reduction.
Therefore we must constantly search for ways of improving
technology. I illustrate this by two examples.
From the earliest days it was known that x-rays cause skin
cancer and in the 1920's it was found that radiation causes leu-
kemia and in the 1930's and 1940's it was found that radiation causes ~
a host of other cancers too. ~
6V. Bond, BNL report.
0)

-10-
In the 1920's physicians pointed out the huge benefits of
rap9.d diagnosis by use of x-rays, and said that the benefits out-
weicrht any conceivable risk due to the x-rays. Of course they
were: right by a reasonable standard. This risk benefit compari-
son was particularly simple because the items were measured in
the same units. X-rays save lives and these can be compared
dire:ctly with lives at risk from the radiation induced cancer.
But the overall comparison of risk and benefit and the
assurance that benefit exceeds risk is only the first question
in a. risk benefit approach. in the 1920's it was pointed out
that. the same benefit of rapid diagnosis by use of x-rays can
be achieved with less risk: more sensitive x-ray film; image
intensifiers; shielding against stray x-rays; and indeed it was
not very expensive to do so. But these risks have only slowly
been reduced, from many rads per x-ray in 1920 to 1 rad in 1950
to 5 millirads today. Why was the reduction slow?
Rachel Carson, in her much misquoted book, Silent Spring,?
agreed that pesticides were important and that the benefits of
their use outweigh the risks. Again, if we think carefully, we
can put at least some of the benefits in the same units as the
risks; fewer pests means more food; more food means better nutri-
tion; better nutrition reduces health risks. But Rachel Carson
insisted it should be possible to have the same benefits with less
risk ;by more careful use.
;[-iow do we ensure that we constantly address this question?
?Carson, R., Silent Spring, Houghton Mifflin, Boston, 1962.

I be].ieve that we must have a continuing decision process. The
proce>.cture in each of the above examples was to show that benefit
> risk and the decision therefore was that the action should pro-
ceed. But in all cases of new technologies it seems appropriate
to look further and ask whether we can reduce the risk with a
modest cost.
In setting the air quality standards for moving sources (auto-
mobiles), Congress demanded a technology forcing approach. The
standa~rds were'set progressively lower in the future and it was
up to the automobile industry to find the technology to meet them.
The i.ndustr
,y screamed, but a Committee of the National Academy of
Sciences chaired by Dr. Edward Ginzton of Varian Associates agreed
that it was technically possible to'meet this standard, and they
are being met.
is this technology forcing procedure the best way for techno-
logy improvement? Congress, after this success, thinks-'so. If we
feel otherwise we must find a better way. I throw on the table
for consideration the following idea. When any new product or
process is accepted, there must be a fraction (1 to 10%) of the
profits spent on a study of the alternatives to the actual action;
other pesticides; less use (including how to restrain overzealous
salesm,en); better x-ray machines--and less x-rays, including how
to prevent,x-rays being taken merely to protect against liability
in a negligence suit. This money could be paid by industry to
NAS or a foundation to do this study.

-12-
I now bring to your attention four separate court and regu-
latory actions that recognize the importance of risk assessment and
its more general extension, risk analysis.
1. The Court of Appeals,8 in the case where FDA questioned
the safety of Monsanto's plastic bottles made with an acrylonitrile
polymer, stated that the administrator of FDA can ignore de minimis
risks, notwithstanding the superficial rigidity of the Delaney Clause.
2. The U.S. Supreme Court decided in the benzene case9 that
the Secretary of Labor for OSHA had to find (technical/legal term)
that -there is a significant health risk before proceeding and by
quoting the one and only risk assessment before the court implied
approval of risk assessment as a procedure for deciding whether a
risk is insignificant or.not. Chief Justice Burger stated that
"inherent in this statutory scheme is the authority to refrain from
regulation of insignificant or de minimis risks."
Although the Court quoted my testimony in this case, they
failed to quote my successful effort at risk reduction. At the
public hearing, the administrative law judge, and half the audi-
ence, were smoking and the room was filled with haze. I objected
to being exposed to such dangerous carcinogens in the workplace.
Now the hearing room is covered with numerous, large "No Smoking"
signs.
8Monsanto,' et al., v. Kennedy, FDAO, 613 F 2nd 947 (DC Circuit)),
1979.
9American Petroleum Institute v. OSHA, et al., 581 F 2nd (DC Cir-
cuit), 1978; 100 S. Ct. 2844 (1980).

-13-
3. Now we have a consent order10 between FDA and several
cosmetic manufacturers. In this "FDA agrees to propose the utili-
zation, of scientifically accepted procedures of risk assessment and
to ra.ise the issue as to whether, in the view of the procedures,
hair dyes containing 4-MMPD present a generally recognized risk to
human health."
4. The FDA made a similar decision in deciding that the risk
of ls:a.d acetate hair dyes (the Grecian formula) is insignificant.
As I look at a 5th case, the cotton dust case, it appears to
be different. It has been argued that the Supreme Court decision
is a repudiation of risk analysis. But we must note that "exposure
to cotton dust represents a significant health hazard to employees,"ll
The health hazard at current levels, acute byssinosis although re-
versible, is directly observable, unlike the effects of benzene at
low doses which is merely inferred by extrapolation. I calculate
with a very rough first guess using the numbers in reference 11 that
the cotton dust standard proposed by OSHA saves cases of byssinosis
(brown lung disease) and hence premature death at a cost of between
$50,000 and $500,000 per case--less than the $1 million per case
often spent to reduce occupational disease, and $10,000,000 to re-
duce occupational death and much less than the $240,000,000 per cal-
culated case I found in my calculations in the benzene case. Of
course, we.would like to understand the connection (if any) between
10Carson Products, et al., v. DHHS, et al., Civil Action No. CV
980-i'1., U.S. District Court for the Southern District of Georgia,
Sept. 1980.
11101. Supreme Court Reporter, p. 2478, American Textile Manufacturers ~
v. Donovan and National Cotton Council of America v. Donovan, 43 Fed. ~
Rea., 27350, col. 1. ®

-14-
acute byssinosis and life shortening effects. Data on this is
scarce and represents a challenge for risk analysts.
My cheerful tentative conclusion is that the Supreme Court be-
have:d with commonsense in both decisions. If OSHA had perfomed a
reasonable risk-benefit analysis it is not obvious that they would
not have reached the same decision, or decided to lower the standard
for cotton dust even lower than 200 yg/m3 until they matched $1,000,000
to $1.0,000,000 per life--unless of course they found other, more
seriaus secondary effects on the economy.
The point here is that, as far as I can tell, there was no
widely accepted risk analysis presented in this case; and OSHA's
decision to take prompt action to tighten the standard is then not
unreasonable.
I now come to several errors that arise from inadequate com-
parisons of risks. For cancer risk calculations, Crouch and 1 12
have been emphasizing the importance of including uncertainties in a
risk calculation. I illustrate this by going over an argument I
had with EPA's director of water quality standards at the Toxico-
logy ;C'orum in February 1981. I objected to his setting of a stand-
ard of 100 ppb for all halomethanes; drinking 2 1/2 liters of water
containing chloroform every day for life can be shown to give a
risk of 4 x 10-5 per year or 3 x 10-4 per life. This is based
on severalassumtions; that the dose response relationship is
linear; that men in their lifetimes have as great a risk of cancer ~
as animals in their lifetimes, when exposed daily to the pollutant ~
~
Edmntnd A.C. Crouch and Richard WIlson, "Interspecies Comparison ~
of Carcinocaenic Potency," Journal of Toxic. and Environ. Health, ~j
1979. Edmjand A.C. Crouch and Richard Wilson, Journal of Risk OA
Analysis, 1, 1 (1981) .

with the same fraction of body weight.
EPA have the same standard for all halomethanes. Yet bromo-
methanes are more toxic and more mutagenic; by skin painting tests
more carcinogenic. The exact amount is uncertain, but it is hard
to see how the risk could fail to be greater at equivalent exposures,
and therefore the standard should be lower.l3 Similarly, tribhlo-
rethelene and perchlorethelene are less toxic, and less carcinogenic
(if carcinogenic at all) and the allowable exposure might reasonably
be greater--or at least it should be explained why it is not.
We can reintroduce the zero risk error in a new form if we
demand too low a risk, and demand too conservative a way of ca1-
culat~~eng it. FDA has proposed14 in a discussion of accidental food
additives such as DES, that'risks less than 10-6 per lifetime (1.4 x
108 per year) be ignored as de minimis and by implication other
risks should be regulated. This is a very low number. Moreover
there are very conservative rules proposed for calculation. By
simple extension of these rules, I would find that many munici-
pal drinking water systems in the U.S. have risks of 10-4 per year.
It is clear that the FDA rule cannot be applied to all situations,
and 9.t: therefore needs more discussion to show just where it should
be applied (if at all). At the present time, most agencies are
inconsistent without saying so.
In the next two figures I show how this comes about. The risk, ~
according to our approach, has 4 factors:
~
~
~
14 Q1
~
~
W
~
~

CA+G (95th percentiley
POTENCY
Species
'Conversion
~'~octor
